Investing in the Future of Healthcare
What this covers
This is a conversation between host Patrick and three RRE partners, Raju Rishi, Jason Black, and Nikita Singareddy, about how a venture firm reads healthcare. Much of it diagnoses why the system behaves as it does. Nikita calls it the principal-agent problem on steroids, because the people choosing care are not the people paying. Jason traces employer-based insurance to its World War I origins as a benefit that hid prices from consumers. Nikita adds detail on opacity: the out-of-pocket share has risen from about 8 to 33 percent, hospitals sued to avoid publishing their chargemaster, and commercial insurer contracts stay undisclosed.
The middle of the discussion moves to the operators. Physicians are described as thinly margined small-business owners who spend roughly two thirds of their time on administration. Government incentives for the electronic health record created billion-dollar vendors but also a documentation burden, and a patient's app can wait about two years in a hospital IT queue. The speakers also cover fee-for-service versus value-based care, the 30-day readmission penalty that drives remote patient monitoring, health savings accounts, and clinical trials built on student volunteers.
The forward-looking half is more contested. Raju argues that interoperability comes first, with other innovations unlocking in sequence. He expects genetics-matched prescribing within his lifetime, and he cites Nebula Genomics' pay-the-patient, blockchain-ownership model, which is a fringe idea. Jason likens missing interoperability to pre-cloud on-premise servers. They also argue that COVID-era telehealth reimbursement and eased cross-state credentialing broke a HIPAA-era firewall and will largely persist.
RRE's partners argue that healthcare is a large, fragmented, wasteful market whose biggest near-term opportunity is data interoperability, and that COVID-19 has broken institutional inertia and will accelerate that shift.
- Healthcare fits RRE's investment framework: it is a multi-trillion-dollar market that technology waves have not yet transformed, it is fragmented, and it is wasteful.
- Interoperability of data is the necessary first step, because the sequence of innovation depends on unlocking the medical record.
- COVID-19 forced regulatory and behavioral changes such as telehealth reimbursement and cross-state credentialing that the speakers expect to persist.
EHR integration and documentation burdens drain clinicians and stall entrepreneurs' products
- A typical doctor spends only about one third of their time seeing patients and two thirds on administrative tasks, which fuels burnout.
“Typical doctor only spends a third of their time actually seeing patients and two thirds of their time doing administrative tasks.”
- Patients now research conditions online and download apps to manage them, but clinicians cannot easily adopt those apps because they do not connect to the electronic health record, and the IT team may quote a two-year integration backlog, creating frustration at every level.
“It's a two-year waiting list. We have 200 apps ahead of you.”
- Medical app and device startups spend about 75 percent of their energy trying to connect to individual EHR systems rather than improving their product, which slows innovation across the sector.
“they're now divesting about 75% of their energy trying to tie in with the individual EHRs”
- Government incentives for electronic health records created billion-dollar vendors almost overnight, but the forced digitization made documentation a massive burden on doctors and nurses, who now spend long hours entering notes after patient visits.
“The government as Nikita said many years ago created this interoperability carrot”
- Speech recognition for charting and third-party note-taking tools that observe visits can cut 15 to 30 minutes of post-visit data entry, and robotic process automation can handle insurance checks and coding, relieving doctors who run practices as small businesses.
“rather than just meeting with the patient and then afterwards spending 15, 20, 30 minutes entering the data”
- Medicine is becoming less lucrative and less attractive to new entrants because of malpractice insurance costs, constant on-call duties, and extra hours spent on data entry, so reducing this tension is necessary to rebuild the workforce.
“It's not as lucrative as it was before. There's a lot of malpractice insurance”
- When a patient brings a health app to a clinician, IT must integrate it into the electronic health record, which can take about two years because hospitals have long queues, so apps stall and the entrepreneur spends most energy on integration rather than the product.
“It's a two-year waiting list. We have 200 apps ahead of you.”
Interoperability is the sequential first step that unlocks all later healthcare innovation
- Healthcare has five stakeholders that matter for innovation: consumers, clinicians, IT staff who run hospital systems, payers, and medical application and device companies.
“I think there's five stakeholders.”
- Markets unlock sequentially rather than in parallel, so healthcare's big first step is interoperability, which lets payers, app developers, and patients use medical data, and then many smaller innovations can follow.
“the opportunity in healthcare is one big step and then a lot of little steps. And the big step to solve first is interoperability.”
- With full interoperability and anonymized data, the next stage is a universal medical record stored in the cloud or on a phone, which would let patients switch doctors easily and let other doctors access all needed data.
“I think the next part of that chain if you got full interoperability would be maybe a universal record.”
COVID permanently moved telehealth, credentialing, and trials forward, though some rules will reverse
- Insurers are accumulating large revenue during COVID because people are not using care while premiums continue, so regulators are likely to step in and push them to return the surplus or lower charges.
“The reason being a lot of these insurance companies are minting money right now.”
- Raju believes COVID has moved healthcare forward by 10 to 20 years through telehealth, credentialing, and eased privacy rules, which he calls profound.
“So I think we've moved forward 10 to 20 years because of COVID in healthcare.”
- When COVID hit, the government required telehealth to be reimbursed at the same level as an in-person visit and eased cross-state credentialing, and doctors and patients embraced it, so the change is unlikely to be fully reversed.
“They started reimbursing telehealth at the same level as an in face doctor's visit. That was profound.”
- Pre-COVID regulation such as HIPAA, which was designed to prevent employers from discriminating based on illness, along with in-office requirements and state-by-state credentialing, created a firewall that prevented much innovation in healthcare.
“But it's created a firewall that has really prevented a lot of innovation in the space.”
- Because of COVID, people are volunteering for clinical trials more readily and tests are being expedited, which is good for speed, though the risk of missing something is unknown, and 2020 is a giant experiment.
“I cannot postulate whether that's good or bad.”
- Nurses and doctors must obtain separate credentials for each state, even though the credentials are about 99.9 percent identical, adding cost and effort without substantive difference.
“Frankly, 99.9% of it's the same, but you just have to go through the effort and the cost associated with it.”
- Some COVID-era rules will reverse because conditions such as heart disease may require in-person analysis for good care, and virtual consults may not match in-person efficacy, so policy will partly swing back while virtual care stays.
“I think the pendulum is going to swing far in one direction and people are going to be like, 'Well no, you really can't do a heart condition analysis without going in.'”
Healthcare fits venture criteria as a fragmented, untouched, wasteful sector worth investing in
- RRE's sector framework has four tests: the market must be a multi-billion or trillion-dollar sector, it should be largely untouched by the major tech discontinuities (internet, mobile, cloud), it should be fragmented with room for standardization and consolidation, and it should have excessive waste or cost, with a regulatory regime that enables entrepreneurship. Healthcare passes all four.
“Our framework is probably four things.”
- Each major technology wave created new billion-dollar markets in music: the internet produced Myspace and Napster, mobile produced Android and iTunes markets, and cloud produced Pandora and Spotify. Healthcare is one of the sectors that has not yet been reshaped by these waves.
“Each of those technology discontinuities has impacted music in a big and profound way.”
- Healthcare was one of the sectors that internet, mobile, and cloud had not meaningfully transformed, which made it a candidate for venture investment, alongside real estate.
“One of the ones we came up with at the time was healthcare. We dove into that. Another one by the way, is real estate.”
- Every hospital system runs uniquely, keeps its data in silos, and uses custom software that does not share data, so the sector is highly fragmented and ripe for standardization and consolidation.
“if you've seen one hospital system, you've seen one hospital system. They all run uniquely. They all keep their data in silos.”
- RRE made an investment in Bend Financial, a company operating in the Health Savings Account space.
“we actually made a bend in a space called Bend Financial”
- About a decade ago RRE supplemented its localized New York strategy with a thesis-driven strategy in which each partner picks a team and a sector, does extensive homework with industry experts and universities, and only then decides whether timing is right.
“I guess 10 years ago, we decided to supplement our localized strategy with a thesis-driven strategy”
Remote patient monitoring will advance only for actionable chronic conditions and penalized readmissions
- If a patient discharged for a chronic issue is readmitted for the same issue within 30 days, the hospital bears the cost, which pushes hospitals to send patients home with remote monitoring kits.
“if in 30 days you're readmitted to that hospital for that same issue, then the hospital and the care team has to eat that cost.”
- Consumer wellness devices such as the Apple Watch, Fitbit, and pulse oximeters are patient-driven and not truly remote patient monitoring, because they are not connected to the doctor, but they will proliferate because devices and app certification are cheap.
“One is just wellness. And I don't think that's remote patient monitoring at all.”
- Even with remote monitoring data flowing in, machine learning will be needed to surface the important signals to clinicians, because doctors do not have time to review raw data every day.
“I think we're going to apply a machine learning layer on top of that to rise some of that data to the surface of the clinician.”
- A fully passive, programmatic diagnostic end state where sensors feed the doctor only when thresholds are crossed is not likely within 10 to 15 years, because the data is not ready.
“I just don't think it comes in the next 10 or 15 years.”
- Remote patient monitoring that matters clinically will be limited to chronic conditions where data is actionable, and to patients discharged from hospitals whose readmission within 30 days is penalized, while consumer wellness devices will remain voluntary.
“Remote patient monitoring, which is actually going to your clinician and your doctor, I think is going to be relegated to two spaces.”
- Remote monitoring devices for chronic patients must be simple to set up because aging America includes many people who are not internet, mobile, or app savvy, so ease of use is a core requirement for adoption.
“with aging America, these devices need to be simple to set up and use”
Data and genetics will enable personalized drug matching, with trial workflows modernized to support it
- Raju believes that matching drugs to individuals based on data and genetics will become standard in his lifetime, and that if interoperability unlocks this, healthcare will have made real progress.
“optimal drug use for my ailment is something I think we'll be able to see in our lifetimes.”
- Clinical trial workflows are offline and paper-driven rather than cloud-based, so trial data reaches pharmaceutical companies in suboptimal form, and modernizing workflows would let sponsors spot problems early and adjust recruitment in real time.
“The workflow is really antiquated. It's not online, it's not cloudified.”
- Anonymized, interoperable data combining treatment outcomes with genetic sequences and ethnic descent could reveal that specific drugs work better for specific groups, such as cancer drugs responding differently to European versus other ancestry, enabling personalized prescribing.
“people in Connecticut and have European descent responded better to this drug.”
- Clinical trials rely on volunteers who are often young students paid for participation, which does not produce representative data, while contract research organizations recruit patients and roll up data into spreadsheets slowly.
“If I get a bunch of 22-year-old, 18-year-old college students taking it because they need extra money, that doesn't necessarily give me the data.”
- Within the speaker's lifetime, doctors may use blood samples and gene analysis to prescribe a drug matched to the patient, building on oncology work by Flatiron Health showing that some cancer drugs work better for specific groups.
“I think we're going to be able to say, like your doctor's going to say, 'Hey, let me do a blood sample and a gene analysis, and prescribe you with a more appropriate drug for you.'”
Consumerization and patient data ownership are pushing patients to take control of their healthcare
- Health Savings Accounts paired with high-deductible plans work like a 401k: employers contribute about $1,000 a year, the money is pre-tax and rolls over, it can be invested, and it must be spent on healthcare, which should make consumers more careful shoppers.
“It's a lot like a 401k. You don't have to use it in a year.”
- Consumerization is a fourth technology force, a prime on top of internet, mobile, and cloud, and it is beginning to make patients take control of their own healthcare.
“But there's a fourth, which is like a prime. I call it like three prime. Which is consumerization.”
- Eric Topol's book The Patient Will See You Now is a useful source on how patients are starting to take control of their healthcare.
“There's an interesting book called The Patient Will See You Now by Eric Topol.”
- Nebula Genomics pays patients for rich gene sequencing and lets them own the data on a blockchain, so pharmaceutical companies pay for the initial sequencing and patients can later earn fees when others use their data, similar to a kickback from ad-tech platforms.
“And then the patient owns the data on the blockchain.”
- A merchant in Raju's childhood village town entertained and returned a wandering four-year-old boy, an act of kindness.
“a merchant there recognized me because I used to come with my mom periodically”